ki 1769 has been researched along with cyclic gmp in 1 studies
Studies (ki 1769) | Trials (ki 1769) | Recent Studies (post-2010) (ki 1769) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
9 | 0 | 1 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | ki 1769 (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Izawa, T; Izumi, H; Jinno, Y; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
1 other study(ies) available for ki 1769 and cyclic gmp
Article | Year |
---|---|
Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
Topics: Animals; Coronary Vessels; Cyclic GMP; Glyburide; In Vitro Techniques; Methylene Blue; Potassium Channels; Pyridines; Swine; Vasodilation; Vasodilator Agents | 1994 |